Concepedia

C Reilly

CR

4

Publications

363

Citations

4

H-Index

1985

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

C Reilly is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryOncologyPhysiologyToxicologyCell BiologyTumor BiologyNeurochemistry

Publications per year

1985–2019

4

Publications

4

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.

Charles Liebow, C Reilly, M. Cruz Sánchez Serrano et al. · Proceedings of the National Academy of Sciences · 1989 · 286 citations · Full text

Chemoprevention Strategy, Several Analogues, Tumor Biology +19

Thirteen Cationic I0n0ph0res: Their Acute Toxicity, Neurobehavioral and Membrane Effects

Shayne C. Gad, C Reilly, K. Siino et al. · Drug and Chemical Toxicology · 1985 · 52 citations

Eye Irritation, Experimental Pharmacology, Toxicological Mechanism +17

Multi-targeting protein-protein interaction inhibitors: Evolution of macrocyclic ligands with embedded carbohydrates (MECs) to improve selectivity

Arvind Negi, C Reilly, Dilip V. Jarikote et al. · European Journal of Medicinal Chemistry · 2019 · 14 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +10

Monocyte chemoattractant protein-1: receptor interactions and calcium signaling mechanisms

M. Needham, Nicholas C. Sturgess, Georgia Cerillo et al. · Journal of Leukocyte Biology · 1996 · 11 citations

Rows per page

1–4 of 4